<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38620971</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2667-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neurology perspectives</Title><ISOAbbreviation>Neurol Perspect</ISOAbbreviation></Journal><ArticleTitle>Persistent headache after COVID-19: Pathophysioloy, clinic and treatment.</ArticleTitle><Pagination><StartPage>S31</StartPage><EndPage>S36</EndPage><MedlinePgn>S31-S36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurop.2021.10.003</ELocationID><Abstract><AbstractText>SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The acute infection is characterised not only by respiratory symptoms, but also by multiple systemic manifestations, including neurological symptoms. Among these, headache is a frequent complaint. As the pandemic progresses and the population of patients recovering from COVID-19 grows, it is becoming apparent that the headache present in the acute stage of the infection may persist for an indeterminate period, becoming a major problem for the patient and potentially leading to disability. In this review we describe the pathophysiological and clinical aspects of persistent headache after COVID-19 based on the information currently available in the literature and the authors' clinical experience.</AbstractText><CopyrightInformation>&#xa9; 2021 Sociedad Espa&#xf1;ola de Neurolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Membrilla</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas Complejas y Dolor Neurop&#xe1;tico, Servicio de Neurolog&#xed;a, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caronna</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Universitario Vall d'Hebron, Departamento de Medicina, Universidad Aut&#xf3;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Cefalea y Dolor Neurol&#xf3;gico, Instituto de Investigaci&#xf3;n Vall d'Hebron, Departamento de Medicina, Universidad Aut&#xf3;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trigo-L&#xf3;pez</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Mart&#xed;nez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de La Princesa e Instituto de Investigaci&#xf3;n Sanitaria La Princesa, Facultad de Medicina, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Layos-Romero</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital General Universitario de Albacete, Albacete, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozo-Rosich</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Universitario Vall d'Hebron, Departamento de Medicina, Universidad Aut&#xf3;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Cefalea y Dolor Neurol&#xf3;gico, Instituto de Investigaci&#xf3;n Vall d'Hebron, Departamento de Medicina, Universidad Aut&#xf3;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrero-Peral</LastName><ForeName>&#xc1;</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas, Servicio de Neurolog&#xed;a, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gago-Veiga</LastName><ForeName>A B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Hospital Universitario de La Princesa e Instituto de Investigaci&#xf3;n Sanitaria La Princesa, Facultad de Medicina, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andr&#xe9;s-L&#xf3;pez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital General de Almansa, Almansa, Albacete, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az de Ter&#xe1;n</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Cefaleas Complejas y Dolor Neurop&#xe1;tico, Servicio de Neurolog&#xed;a, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria del Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neurol Perspect</MedlineTA><NlmUniqueID>9918557088306676</NlmUniqueID><ISSNLinking>2667-0496</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="spa"><AbstractText>El SARS-CoV-2 (S&#xed;ndrome Respiratorio Agudo Grave &#x2013; Coronavirus 2) es el virus responsable de la pandemia por la Enfermedad por el Coronavirus de 2019 (COVID-19). La fase aguda de la enfermedad se caracteriza no s&#xf3;lo por s&#xed;ntomas respiratorios, sino que el cuadro cl&#xed;nico puede estar acompa&#xf1;ado de m&#xfa;ltiples s&#xed;ntomas sist&#xe9;micos, incluyendo los neurol&#xf3;gicos. Entre ellos, la cefalea es una queja frecuente. A medida que avanza la pandemia y crece la poblaci&#xf3;n de pacientes que se recuperan del COVID-19, se est&#xe1; observando que la cefalea presente en la fase aguda de la infecci&#xf3;n puede persistir durante un periodo de tiempo indeterminado, convirti&#xe9;ndose un problema capital para el paciente y llegando a condicionar discapacidad. En esta revisi&#xf3;n proporcionamos informaci&#xf3;n acerca de los aspectos fisiopatol&#xf3;gicos y cl&#xed;nicos de la cefalea persistente tras el COVID-19 en base a la informaci&#xf3;n disponible en la literatura actual y la experiencia cl&#xed;nica de los autores.</AbstractText><CopyrightInformation>&#xa9; 2021 Sociedad Espa&#xf1;ola de Neurolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">New daily persistent headache</Keyword><Keyword MajorTopicYN="N">SARS-COV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>14</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38620971</ArticleId><ArticleId IdType="pmc">PMC8669731</ArticleId><ArticleId IdType="doi">10.1016/j.neurop.2021.10.003</ArticleId><ArticleId IdType="pii">S2667-0496(21)00068-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Membrilla J.A., de Lorenzo &#xcd;., Sastre M., D&#xed;az de Ter&#xe1;n J. Headache as a cardinal symptom of coronavirus disease 2019: a cross-sectional study. Headache. 2020;60:2176&#x2013;2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646273</ArticleId><ArticleId IdType="pubmed">32989732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Martinez A., et al. Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case&#x2013;control study. Eur J Neurol. 2021:1&#x2013;11. doi: 10.1111/ene.14718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14718</ArticleId><ArticleId IdType="pubmed">33417287</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J., et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain. 2020;21:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388434</ArticleId><ArticleId IdType="pubmed">32727345</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahearn-Ford S., et al. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection. Allergy. 2021;76:2910&#x2013;2913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222932</ArticleId><ArticleId IdType="pubmed">34028045</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D., et al. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect. 2021;82:e1&#x2013;e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., et al. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses. JCI Insight. 2021 doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., et al. Evolution of antibody immunity to SARS-CoV-2. bioRxiv Prepr Serv Biol. 2021 doi: 10.1101/2020.11.03.367391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.03.367391</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhadelia N., et al. Distinct autoimmune antibody signatures between hospitalized acute COVID-19 patients, SARS-CoV-2 convalescent individuals, and unexposed pre-pandemic controls. medRxiv. 2021 doi: 10.1101/2021.01.21.21249176. 2021.01.21.21249176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.21.21249176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dub&#xe9; M., et al. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6096804</ArticleId><ArticleId IdType="pubmed">29925652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann C.C., Lane T.E., Stohlman S.A. Coronavirus infection of the central nervous system: host&#x2013;virus stand-off. Nat Rev Microbiol. 2006;4:121&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7096820</ArticleId><ArticleId IdType="pubmed">16415928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarchielli P., et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache J Head Face Pain. 2006;46:200&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16492228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6 eabc5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasek M.J., et al. A complement&#x2013;microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534:538&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452615</ArticleId><ArticleId IdType="pubmed">27337340</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P.D., Klein R.S. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78:682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>De Virgiliis F., Di Giovanni S. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat Rev Neurol. 2020;16:645&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7446605</ArticleId><ArticleId IdType="pubmed">32843733</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernuda-Morollon E., et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81:1191&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">23975872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen J.M., Hauge A.W., Olesen J., Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30:1179&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">20855363</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyengar S., Johnson K.W., Ossipov M.H., Aurora S.K. CGRP and the trigeminal system in migraine. Headache. 2019;59:659&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593989</ArticleId><ArticleId IdType="pubmed">30982963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H., et al. HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain. 2021;22:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8358545</ArticleId><ArticleId IdType="pubmed">34384355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa-Callejero L., et al. Circulating levels of calcitonin gene-related peptide are lower in COVID-19 patients. J Endocr Soc. 2021;5 bvaa199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798995</ArticleId><ArticleId IdType="pubmed">33506161</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Alpuente A., Torres-Ferrus M., Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: three migraine-like yet distinct scenarios. Headache J Head Face Pain. 2021;61:1277&#x2013;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D., et al. Frequency and type of red flags in patients with Covid-19 and headache: a series of 104 hospitalized patients. Headache. 2020;60:1664&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436570</ArticleId><ArticleId IdType="pubmed">32790215</ArticleId></ArticleIdList></Reference><Reference><Citation>Poncet-Megemont L., et al. High prevalence of headaches during Covid-19 infection: a retrospective cohort study. Headache. 2020;60:2578&#x2013;2582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436456</ArticleId><ArticleId IdType="pubmed">32757419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho P.A., Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. 2020;60:1797&#x2013;1799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436496</ArticleId><ArticleId IdType="pubmed">32790179</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamani N., Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. J Headache Pain. 2019;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6734284</ArticleId><ArticleId IdType="pubmed">31307396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozen T.D. Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu. Cephalalgia. 2020;40:1406&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645599</ArticleId><ArticleId IdType="pubmed">33146034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021 doi: 10.7326/M21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes A.W., et al. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021;7:00141&#x2013;02021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J., et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021;27:1041.e1&#x2013;1041.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., et al. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021 doi: 10.1177/03331024211020404. 033310242110204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211020404</ArticleId><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., et al. Previous history of migraine is associated with fatigue, but not headache, as long-term post-COVID symptom after severe acute respiratory SARS-CoV-2 infection: a case-control study. Front Hum Neurosci. 2021;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290894</ArticleId><ArticleId IdType="pubmed">34295230</ArticleId></ArticleIdList></Reference><Reference><Citation>Headache Classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamont M.S., Alias A.C., N. A, Win M.N. Red flags in patients presenting with headache: clinical indications for neuroimaging. Br J Radiol. 2003;76:532&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">12893694</ArticleId></ArticleIdList></Reference><Reference><Citation>Do T.P., et al. Red and orange flags for secondary headaches in clinical practice. Neurology. 2019;92:134&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6340385</ArticleId><ArticleId IdType="pubmed">30587518</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Lasaosa S., et al. Recomendaciones de la Sociedad Espa&#xf1;ola de Neurolog&#xed;a; Ediciones SEN: 2020. Manual de cefaleas de pr&#xe1;ctica cl&#xed;nica en cefaleas.</Citation></Reference><Reference><Citation>Blumenfeld A., et al. Method of injection of onabotulinumtoxina for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache J Head Face Pain. 2010;50:1406&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">20958294</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Lasaosa S., Porta-Etessam J. OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection. Neurologia. 2020;35:291&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221361</ArticleId><ArticleId IdType="pubmed">32410765</ArticleId></ArticleIdList></Reference><Reference><Citation>Maassenvandenbrink A., De Vries T., Danser A.H.J. Headache medication and the COVID-19 pandemic. J Headache Pain. 2020;21:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183387</ArticleId><ArticleId IdType="pubmed">32334535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>